Cyclosporin A in myelodysplastic syndrome: A preliminary report

Annals of Hematology

Volumn 84, Issue 9, 2005, Pages 565-568

  Dixit, Ashish ^a   Chatterjee, Tathagat ^a   Mishra, Pravas ^a   Choudhary, Dharma R ^a   Mahapatra, Manoranjan ^a   Saxena, Renu ^a   Choudhry, Ved P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cyclosporin A; Hypoplastic MDS; Immunosuppressive therapy; MDS; Myelodysplastic syndrome

Indexed keywords

CYCLOSPORIN A; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RELAPSE; SEPTICEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; UREMIA;

ADULT; AGED; ANEMIA, REFRACTORY; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANEMIA, SIDEROBLASTIC; BONE MARROW; CYCLOSPORINE; FEMALE; HUMANS; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PLATELET COUNT; TREATMENT OUTCOME;

EID: 23944523111     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1016-6     Document Type: Article

References (21)

1. Koeffler HP (1996) Myelodysplastic syndromes. Semin Hematol 33:87-94
2. Kouides PA, Bennet JM (1996) Morphology and classification of myelodysplastic syndrome and their pathological variants. Semin Hematol 33:95-110
3. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennet JM (1995) Hypocellular myelodysplastic syndrome: New proposals. Br J Haematol 91:612-617
4. Fohlmeister I, Fischer R, Modder B, Rister M, Shaeffer HE (1985) Aplastic anemia and hypoplastic myelodysplastic syndrome: histomorphological, diagnostic and prognostic features. J Clin Pathol 38:1218-1224
5. Bacigalupo A, Broccia G, Corda D, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G et al (1995) Antithymocyte globulin, cyclosporine and granulocyte colony stimulating factor in patients with acquired aplastic anemia (SAA): A pilot study of EBMT SAA working party. Blood 85:1348-1353
6. Miescher PA, Favre H, Beris P (1991) Autoimmune myelodysplasias. Semin Hematol 28:322-330
7. Muller EW, De Wolfe JT, Vallenga E (1993) Successful immunosuppressive treatment after failure of erythropoietic therapy in two subjects with refractory anemia. Br J Hematol 83:171-172
8. Biesma DH, van den Tweel JG, Verdonck IF (1997) Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 79:1548-1551
9. Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M, Hochova I (1998) Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 100:304-309
10. Shimamoto T, Iguchi T, Ando K, Katagiri T, Tauchi T, Ito Y, Yaguchi M, Kimura Y, Masuda M, Mizoguchi H, Ohyashiki K (2001) Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol 114:358-361
11. Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ (1997) Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 99:699-705
12. Asano Y, Maeda M, Uchida N, Yokoyama T, Osaki K, Shimoda K, Gondo H, Okamura T, Okamura S, Niho Y (2001) Immunosuppressive therapy for patients with refractory anemia. Ann Hematol 80:634-638
13. Imai Y, Fukuoka T, Nakatani A, Ohsaka A, Takahashi A (1996) Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone. Br J Haematol 93:146-150
14. Cheson BD, Bennet JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Lowenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL (2000) Report of an international working group to standardize response criteria for myelodysplastic syndrome. Blood 96:3671-3674 1:CAS:528:DC%2BD3cXosVGnt7o%3D
15. Enright H, Jacob SH, Vercellotti G, Howe R, Belzer M, Miller W (1995) Paraneoplastic autoimmune phenomenon in patients with myelodysplastic syndrome: Response to immunosuppressive therapy. Br J Haematol 91:403-408
16. Young NS (1992) Problem of clonality in aplastic anemia. Blood 79:1385-1392
17. Hamblin TJ (1996) Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 33:150-162
18. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA (1986) Immunological abnormalities in myelodysplastic syndromes. Br J Haematol 63:143-147
19. Editorial (1985) Cyclosporine in autoimmune disease. Lancet i:211-909
20. Trucco M, Rovera G, Ferrero D (1984) A novel human lymphokine that inhibits hematopoietic progenitor cell proliferation. Nature 309:166-168
21. Nand S, Godwin JE (1988) Hypoplastic myelodysplastic syndrome. Cancer 62:958-962